Cassady Schiller Wealth Management’s Repligen RGEN Stock Holding History

Cassady Schiller Wealth Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$576	Buy	+4	New	+$574	﹤0.01%	931

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Cassady Schiller Wealth Management's RGEN Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Repligen (RGEN) in Q4 2024: 4 shares worth $576. The stake represents ﹤0.01% of the portfolio and ranks #931 among its holdings.

430 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

Cassady Schiller Wealth Management held 4 shares of Repligen worth $576 as of Q4 2024.
Repligen was a new Cassady Schiller Wealth Management position in Q4 2024.
Repligen made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #931 holding.
430 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.